What is AAPG's health score?

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is AAPG's estimated fair value?

Based on our 5-year discounted cash flow model, ASCENTAGE PHARMA GROUP INTERNATIONAL's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is AAPG undervalued or overvalued?

Our model currently rates AAPG as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Healthcare Inconclusive inconclusive weak

$19.24

Updated: 2026-07-14

TradeApes Score

Financial Strength

35 Weak

Operating Trend

48 Mixed

Relative Value

40 Weak

Capital Allocation

45 Mixed

Risk Management

65 Healthy

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Industry Related Stocks

Aardvark Therapeutics, Inc. (AARD) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH) AbbVie Inc. (ABBV) AbCellera Biologics Inc. (ABCL) ABEONA THERAPEUTICS INC. (ABEO)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.